Clinical significance of human papillomavirus genotyping
- PMID: 26768784
- PMCID: PMC4717226
- DOI: 10.3802/jgo.2016.27.e21
Clinical significance of human papillomavirus genotyping
Abstract
Cervical cancer is the fourth most common cancer in women worldwide, and the human papillomavirus (HPV) is the main causative agent for its development. HPV is a heterogeneous virus, and a persistent infection with a high-risk HPV contributes to the development of cancer. In recent decades, great advances have been made in understanding the molecular biology of HPV, and HPV's significance in cervical cancer prevention and management has received increased attention. In this review, we discuss the role of HPV genotyping in cervical cancer by addressing: clinically important issues in HPV virology; the current application of HPV genotyping in clinical medicine; and potential future uses for HPV genotyping.
Keywords: DNA Tests; Genotype; Human Papillomavirus; Uterine Cervical Neoplasms; Vaccine.
Conflict of interest statement
Figures
References
-
- zur Hausen H. Papillomaviruses in the causation of human cancers: a brief historical account. Virology. 2009;384:260–265. - PubMed
-
- International Human Papillomavirus Reference Center. Human papillomavirus reference clones [Internet] Stockholm, SE: International Human Papillomavirus Reference Center; c2015. [cited 2015 Nov 6]. Available from: http://www.hpvcenter.se/html/refclones.html.
-
- de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:17–27. - PubMed
-
- Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ. 2002;325:572. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
